Core Laboratories N.V.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
8.738.437.807.06
Price/Sales ratio
0.830.820.800.77
Earnings per Share (EPS)
$1.19$1.24$1.34$1.48

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
20.3940.1281.6858.1833.1616.38-12.1452.0348.2722.4725.7816.38
Price/Sales ratio
4.835.778.777.333.762.502.412.181.911.611.502.50
Price/Book Value ratio
55.86-194.4333.6032.5216.399.1715.606.374.973.663.139.17
Price/Cash Flow ratio
17.3021.0339.5738.9223.5818.6620.3728.0637.6333.2514.2918.66
Price/Free Cash Flow ratio
19.7423.6443.4245.8429.2724.8425.6344.5563.7158.0117.9824.84
Price/Earnings Growth ratio
2.11-0.74-1.751.96-7.790.950.05-0.42-2.730.25-1.18-7.79
Dividend Yield
1.69%2.04%1.82%2.00%3.68%5.83%1.05%0.17%0.19%0.22%0.23%5.83%
Profitability Indicator Ratios
Gross Profit Margin
36.23%29.76%21.05%24.34%25.79%22.45%18.80%17.82%16.11%18.44%17.56%22.45%
Operating Profit Margin
31.93%20.19%14.49%17.04%16.92%14.46%11.44%9.62%8.47%10.71%10.90%14.46%
Pretax Profit Margin
30.95%18.64%12.54%15.41%15.02%12.27%-18.71%7.67%6.11%8.08%8.72%12.27%
Net Profit Margin
23.72%14.40%10.74%12.59%11.34%15.26%-19.92%4.19%3.97%7.19%5.82%15.26%
Effective Tax Rate
23.01%22.70%14.40%18.29%24.16%-14.98%-6.46%44.00%34.37%10.15%31.18%24.16%
Return on Assets
38.10%18.36%11.14%14.21%12.25%13.16%-17.07%3.39%3.36%6.25%5.07%13.16%
Return On Equity
273.94%-484.60%41.14%55.88%49.42%55.99%-128.44%12.25%10.29%16.31%12.85%55.99%
Return on Capital Employed
63.72%31.92%18.37%23.43%21.71%14.58%11.64%9.23%8.73%10.96%11.27%14.58%
Liquidity Ratios
Current Ratio
2.281.971.791.972.251.981.84N/AN/AN/A2.472.25
Quick Ratio
1.951.631.461.651.801.531.421.581.461.711.781.78
Cash ratio
0.170.180.140.130.120.090.150.190.140.170.220.12
Days of Sales Outstanding
66.3166.6770.1673.6267.2671.8762.3175.1579.6888.1192.4167.26
Days of Inventory outstanding
22.8726.6526.2124.3632.0435.3335.1942.9253.7062.9555.4632.04
Operating Cycle
89.1993.3396.3797.9899.31107.2097.51118.08133.38151.06147.8799.31
Days of Payables Outstanding
24.8321.8126.2130.4828.8825.0821.2428.0740.7329.4128.4728.47
Cash Conversion Cycle
64.3571.5270.1667.5070.4282.1276.2690.0092.65121.64119.3970.42
Debt Ratios
Debt Ratio
0.520.680.370.380.440.390.450.320.290.270.250.39
Debt Equity Ratio
3.76-18.181.391.521.801.673.431.170.910.720.601.67
Long-term Debt to Capitalization
0.791.050.580.600.640.620.770.530.470.420.350.62
Total Debt to Capitalization
0.791.050.580.600.640.620.770.530.470.420.370.62
Interest Coverage Ratio
32.6813.017.5510.248.906.584.00N/AN/AN/A4.266.58
Cash Flow to Debt Ratio
0.850.500.600.540.380.290.220.190.140.150.360.36
Company Equity Multiplier
7.18-26.383.693.934.034.257.523.603.062.602.394.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.270.270.220.180.150.130.110.070.050.040.100.13
Free Cash Flow / Operating Cash Flow Ratio
0.870.880.910.840.800.750.790.620.590.570.790.79
Cash Flow Coverage Ratio
0.850.500.600.540.380.290.220.190.140.150.360.36
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.80N/A
Dividend Payout Ratio
34.59%82.05%148.90%116.86%122.28%95.67%-12.82%9.29%9.52%5.09%6.07%95.67%